Cannabis Act

From WikiMD's WELLNESSPEDIA

Cannabis Act is a law that was passed in Canada in 2018 to legalize and regulate the production, distribution, and use of cannabis. The Act was introduced by the Liberal Party of Canada, led by Justin Trudeau, as part of their 2015 election campaign promise to legalize cannabis.

Background[edit]

The Cannabis Act, also known as Bill C-45, was introduced in the House of Commons of Canada on April 13, 2017, by the Minister of Justice and Attorney General of Canada, Jody Wilson-Raybould. The Act was passed by the House of Commons on November 27, 2017, and by the Senate of Canada on June 7, 2018. It received Royal Assent on June 21, 2018, and came into effect on October 17, 2018.

Provisions[edit]

The Cannabis Act allows adults to possess up to 30 grams of dried cannabis in public. It also allows households to grow up to four cannabis plants for personal use. The Act also establishes a regulatory framework for the production, distribution, sale, and possession of cannabis across Canada. It also sets penalties for offenses under the Act.

Regulation[edit]

The Cannabis Act is regulated by Health Canada and the Canada Border Services Agency. The Act also gives provinces and territories the authority to regulate certain aspects such as distribution and retail sales.

Criticism[edit]

The Cannabis Act has been criticized for various reasons. Some critics argue that the Act does not go far enough in decriminalizing cannabis, while others argue that it goes too far and could lead to increased use, especially among young people.

See also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.